Spire Healthcare (‘Spire’) was the second largest private hospital group in the UK, operating out of 39 acute care hospitals and 13 outpatient clinics. Spire delivered tailored, personalised care to its patients, whether funded through private medical insurance (‘PMI’) or paying for their own treatment (‘self-pay’). Spire also used its capacity to treat National Health Service (‘NHS’) patients under the UK Government’s Patient Choice scheme.
In July 2014, Cinven successfully completed the IPO of Spire on the London Stock Exchange. Cinven fully realised its investment in July 2015, following the sale of several tranches of shares, including selling a 29.9% stake in Spire to South African strategic, Remgro.